[
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory",
    "summary": "We came across a bullish thesis on Regeneron Pharmaceuticals, Inc. (REGN) on Notes From The Beauty Contest’s Substack. In this article, we will summarize the bulls’ thesis on REGN. Regeneron Pharmaceuticals, Inc. (REGN)’s share was trading at $605.39 as of 29th May. REGN’s trailing and forward P/E were 15.39 and 17.39 respectively according to Yahoo Finance. Regeneron’s […]",
    "url": "https://finnhub.io/api/news?id=f05810601e7e27c3b367a0c55bdb45f04a38815390985f3902e153429a0d2031",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749230827,
      "headline": "Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory",
      "id": 135082814,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "We came across a bullish thesis on Regeneron Pharmaceuticals, Inc. (REGN) on Notes From The Beauty Contest’s Substack. In this article, we will summarize the bulls’ thesis on REGN. Regeneron Pharmaceuticals, Inc. (REGN)’s share was trading at $605.39 as of 29th May. REGN’s trailing and forward P/E were 15.39 and 17.39 respectively according to Yahoo Finance. Regeneron’s […]",
      "url": "https://finnhub.io/api/news?id=f05810601e7e27c3b367a0c55bdb45f04a38815390985f3902e153429a0d2031"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "summary": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=954545c828be053d51395c5b82eb2fd844691e97e6c8e7ebf23bc0cceb55677c",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749228480,
      "headline": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "id": 135096698,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=954545c828be053d51395c5b82eb2fd844691e97e6c8e7ebf23bc0cceb55677c"
    }
  },
  {
    "ts": null,
    "headline": "Can New Cancer Drug Emrelis Drive AbbVie's Oncology Franchise?",
    "summary": "Emrelis wins FDA approval, marking ABBV's first lung cancer drug and strengthening its oncology reach into solid tumors.",
    "url": "https://finnhub.io/api/news?id=1b513ffce8a0637b9eca81d442bce3dcc1d42a08523f9468515cc071405b6017",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749215520,
      "headline": "Can New Cancer Drug Emrelis Drive AbbVie's Oncology Franchise?",
      "id": 135078197,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Emrelis wins FDA approval, marking ABBV's first lung cancer drug and strengthening its oncology reach into solid tumors.",
      "url": "https://finnhub.io/api/news?id=1b513ffce8a0637b9eca81d442bce3dcc1d42a08523f9468515cc071405b6017"
    }
  }
]